跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Quadcomb - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Quadcomb
Approved
STANDARD
Quadcomb
Ashford Pharmaceutical Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
df1d192a4b35d06e
Company
Ashford Pharmaceutical Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
df1d192a4b35d06e
Drug Approval Philippines Name
Quadcomb
Product Name
Quadcomb
Registration Number
DR-XY37789
Brand Name
Quadcomb
Generic Name
Triamcinolone Acetonide + Neomycin (As Sulfate) + Gramicidin + Nystatin
Dosage Form
Otic Suspension
Dosage Strength
1mg/2.5mg/250mcg/100,000units per mL
Manufacturer
Ashford Pharmaceutical Laboratories, Inc.
Trader
Optaderm Pharma, Inc.
Issuance Date
29 May 2023
Expiry Date
25 June 2028
Pharmacologic Category
Cortecosteroid/Antibacterial/Antifungal
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
df1d192a4b35d06e
Type
Standard
Back to Philippines FDA Approvals